Alignment Healthcare, Inc. (NASDAQ:ALHC) Given Average Rating of “Hold” by Analysts

Alignment Healthcare, Inc. (NASDAQ:ALHC) has earned an average rating of “Hold” from the nine research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $9.18.

ALHC has been the topic of several research analyst reports. Stephens lifted their target price on shares of Alignment Healthcare from $10.00 to $10.50 and gave the company an “equal weight” rating in a research report on Tuesday, January 9th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research report on Wednesday, March 6th. Stifel Nicolaus decreased their price objective on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating on the stock in a report on Tuesday. Barclays assumed coverage on shares of Alignment Healthcare in a report on Wednesday, March 6th. They set an “underweight” rating and a $4.50 target price for the company. Finally, Raymond James raised their price target on shares of Alignment Healthcare from $10.00 to $12.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, January 9th.

Insider Activity

In related news, CFO Robert Thomas Freeman sold 11,858 shares of the stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $4.89, for a total value of $57,985.62. Following the completion of the transaction, the chief financial officer now directly owns 898,228 shares in the company, valued at $4,392,334.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Alignment Healthcare news, insider Dawn Christine Maroney sold 23,000 shares of Alignment Healthcare stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $5.44, for a total transaction of $125,120.00. Following the completion of the sale, the insider now directly owns 1,830,008 shares in the company, valued at $9,955,243.52. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Robert Thomas Freeman sold 11,858 shares of the business’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $4.89, for a total transaction of $57,985.62. Following the completion of the sale, the chief financial officer now directly owns 898,228 shares in the company, valued at $4,392,334.92. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 90,213 shares of company stock valued at $460,587. 6.30% of the stock is currently owned by company insiders.

Institutional Trading of Alignment Healthcare

Several institutional investors have recently added to or reduced their stakes in ALHC. Barlow Wealth Partners Inc. acquired a new position in Alignment Healthcare during the fourth quarter worth $100,000. Victory Capital Management Inc. lifted its stake in Alignment Healthcare by 17.9% during the 4th quarter. Victory Capital Management Inc. now owns 12,935 shares of the company’s stock worth $111,000 after acquiring an additional 1,962 shares in the last quarter. Teza Capital Management LLC acquired a new position in Alignment Healthcare during the 3rd quarter worth about $109,000. Aigen Investment Management LP acquired a new position in Alignment Healthcare in the 3rd quarter valued at about $116,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Alignment Healthcare by 75.5% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,427 shares of the company’s stock valued at $183,000 after acquiring an additional 11,370 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Stock Up 3.4 %

ALHC opened at $5.18 on Wednesday. Alignment Healthcare has a fifty-two week low of $4.46 and a fifty-two week high of $9.20. The company has a debt-to-equity ratio of 1.02, a quick ratio of 1.84 and a current ratio of 1.84. The stock has a market capitalization of $978.92 million, a price-to-earnings ratio of -6.56 and a beta of 1.30. The company has a fifty day moving average of $5.30 and a two-hundred day moving average of $6.63.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.03). The business had revenue of $465.39 million during the quarter, compared to analyst estimates of $444.56 million. Alignment Healthcare had a negative net margin of 8.12% and a negative return on equity of 75.64%. The firm’s revenue for the quarter was up 28.6% on a year-over-year basis. During the same period in the previous year, the business posted ($0.31) earnings per share. On average, research analysts expect that Alignment Healthcare will post -0.59 earnings per share for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.